EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Immunoinformatic analysis of haemagglutinin-neuraminidase protein to reveal molecular immunogenicity of Newcastle disease virus between vaccine and Indonesian strain

F. P. C. Santoso, L. Angeliya, M. H. Wibowo

BULGARIAN JOURNAL OF VETERINARY MEDICINE · 2025-12-01 · 28 (4) · 717

DOI: 10.15547/bjvm.2024-0115 ↗
AbstractBibliografische Angaben

Abstract

Newcastle disease (ND) is a significant avian disease in Indonesia, causing substantial economic losses in poultry production. Despite vaccination efforts, ND outbreaks persist, raising questions about vaccine efficacy. This study investigates the molecular immunogenicity of the haemagglutinin-neuraminidase (HN) protein between the widely used Lasota vaccine strain and Indonesian Newcastle disease virus (NDV) strains. Phylogenetic analysis revealed two main clusters, with the Lasota strain showing 86.1-99.8% identity to Indonesian strains. Secondary structure analysis and epitope predictions highlighted key antigenic differences, including mutations in critical epitopes. Only 8.9% of Lasota’s predicted B- and T-cell epitopes were conserved in Indonesian strains, suggesting limited cross-protection. The findings suggest that molecular variations in the HN protein may contribute to ND recurrence in vaccinated flocks by allowing immune evasion. This emphasises the need for vaccines tailored to the molecular characteristics of circulating strains. By leveraging immunoinformatic tools, this study provides insights into the design of improved vaccines that target both humoral and cellular immune responses. In conclusion, significant differences in immunogenicity between the Lasota and Indonesian NDV strains underline the importance of updating vaccine strategies. These findings are critical for ND control in Indonesia and have broader implications for global vaccine development against evolving NDV strains.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →